UBS Group AG - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 76 filers reported holding IMMUNE DESIGN CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$28,000
-15.2%
4,765
-81.0%
0.00%
Q4 2018$33,000
-15.4%
25,100
+125.9%
0.00%
Q3 2018$39,000
+44.4%
11,111
+89.5%
0.00%
Q2 2018$27,000
+440.0%
5,863
+352.0%
0.00%
Q4 2017$5,000
-16.7%
1,297
+130.4%
0.00%
Q3 2017$6,000
+50.0%
563
+29.4%
0.00%
Q2 2017$4,000
+33.3%
435
-0.7%
0.00%
Q1 2017$3,000
-90.6%
438
-92.5%
0.00%
Q4 2016$32,000
-51.5%
5,826
+76.5%
0.00%
Q4 2015$66,000
+2100.0%
3,301
+1194.5%
0.00%
Q3 2015$3,000
-88.5%
255
-69.4%
0.00%
Q4 2014$26,0008320.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2017
NameSharesValueWeighting ↓
Svennilson Peter 6,642,942$8,636,0007.61%
Versant Venture Management, LLC 2,208,210$2,870,673,0001.42%
BVF INC/IL 5,185,383$6,741,0000.88%
EcoR1 Capital, LLC 5,603,191$7,284,0000.73%
Abingworth LLP 352,300$458,0000.42%
Bain Capital Public Equity Management, LLC 892,061$1,160,0000.11%
ALGERT GLOBAL LLC 92,591$120,0000.03%
GSA CAPITAL PARTNERS LLP 41,068$53,0000.01%
OXFORD ASSET MANAGEMENT LLP 136,468$177,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 27,122$35,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders